These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7396995)

  • 41. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors.
    Sokoloff P; Martres MP; Schwartz JC
    Nature; 1980 Nov; 288(5788):283-6. PubMed ID: 7432527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
    Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
    J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
    Bacopoulos NG
    Biochem Pharmacol; 1982 Oct; 31(19):3085-91. PubMed ID: 7150335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain.
    Gehlert DR; Gackenheimer SL; Seeman P; Schaus J
    Eur J Pharmacol; 1992 Feb; 211(2):189-94. PubMed ID: 1351846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraventricular injection of neurotensin reduces the binding of dopamine D-2 receptors in the rat forebrain.
    von Euler G; Meister B; Hökfelt T; Fuxe K
    Acta Physiol Scand; 1989 Oct; 137(2):309-10. PubMed ID: 2618764
    [No Abstract]   [Full Text] [Related]  

  • 49. Alterations in brain opiate receptors in Parkinson's disease.
    Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
    Brain Res; 1979 Sep; 173(2):378-82. PubMed ID: 226215
    [No Abstract]   [Full Text] [Related]  

  • 50. Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices.
    Davidson B; Kurstjens NP; Patton J; Cantrill RC
    Eur J Pharmacol; 1988 May; 149(3):317-22. PubMed ID: 2900769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved high-affinity binding of 3H-apomorphine with a subcellular membrane fraction of mammalian brain tissue.
    Arana GW; Baldessarini RJ; Herschel M; Fava M
    Life Sci; 1981 Jul; 29(2):121-33. PubMed ID: 6270486
    [No Abstract]   [Full Text] [Related]  

  • 53. Hallucinogen binding to dopamine/neuroleptic receptors.
    Whitaker PM; Seeman P
    J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
    [No Abstract]   [Full Text] [Related]  

  • 54. Alterations in [3H]desmethylimipramine binding in the aged rat brain: an in vitro autoradiographic demonstration.
    Rapp PR; Fanelli RF; McGuire M; Rosenberg RA; Gallagher M
    Neurosci Lett; 1987 Aug; 79(1-2):17-22. PubMed ID: 3670726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction in number of dopamine uptake sites but unchanged number of piperazine-acceptor/CYP450IID6 binding sites in the human caudate nucleus in aging.
    Norlén M; Allard P
    Neurosci Lett; 1996 May; 209(3):161-4. PubMed ID: 8736635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased density of human striatal dopamine uptake sites with age.
    Zelnik N; Angel I; Paul SM; Kleinman JE
    Eur J Pharmacol; 1986 Jul; 126(1-2):175-6. PubMed ID: 3758163
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased binding of [3H]apomorphine in caudate membranes after dopamine pretreatment in vitro.
    McManus C; Hartley EJ; Seeman P
    J Pharm Pharmacol; 1978 Jul; 30(7):444-7. PubMed ID: 27612
    [No Abstract]   [Full Text] [Related]  

  • 58. Dopamine histofluorescence in post-mortem specimens of human and rat striatum.
    Chase TN; Balch TS; Jacobowitz DM
    J Psychiatr Res; 1974; 11():281-2. PubMed ID: 4461797
    [No Abstract]   [Full Text] [Related]  

  • 59. Fast electrochemical studies in isolated tissues.
    Kruk ZL; O'Connor JJ
    Trends Pharmacol Sci; 1995 May; 16(5):145-9. PubMed ID: 7624968
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--I. In vitro studies.
    Blanchard JC; Boireau A; Garret C; Julou L
    Biochem Pharmacol; 1980 Nov; 29(21):2933-8. PubMed ID: 6109531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.